Practical Disease Concepts in Epidemiology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
OSU Infectious Diseases Response Protocol
DocuSign Envelope ID: D09C67E0-CB87-454C-8430-DBD2BA83D21A Student Health Services 108 SW Memorial Place, Plageman Bldg Corvallis, OR 97331 P 541-737-9355 | F 541-737-9665 Studenthealth.oregonstate.edu OSU Infectious Diseases Response Protocol Oregon State University Student Health Services 108 SW Memorial Place Plageman Building Corvallis, OR 97331-5801 Revised July 2019 Oregon State University Infectious Diseases Response Team Student Health Services (SHS) Office of Student Life Department of Public Safety (DPS) Emergency Management Facilities Services ABM (Custodial Contract Services) Division of International Programs INTO OSU Risk Management Environmental Health and Safety (EHS) Center for Fraternity and Sorority Life (CFSL) University Relations and Marketing (URM) University Housing and Dining Services (UHDS) Counseling and Psychological Services (CAPS) Summer Session Enrollment Management-Office of Admissions Department of Recreational Sports Academic Advising Athletics Department Benton County Health Services (BCHS) Good Samaritan Regional Medical Center (GSRMC) Corvallis Fire Department (Emergency Medical Services) DocuSign Envelope ID: D09C67E0-CB87-454C-8430-DBD2BA83D21A Page 2 of 47 Promulgation, Approval, and Implementation The following is the Infectious Disease Response Protocol (IDRP) for Oregon State University (OSU). It identifies strategies and responsibilities for the prevention of and implementation of an emergency response to communicable diseases in the OSU community. This plan applies to all visitors, staff, students, volunteers or others working in OSU buildings. This plan has been approved and adopted by the OSU Infectious Disease Response Team (IDRT) and Benton County Health Services. It will be revised and updated as required. This plan supersedes any previous plan. It is understood that emergency plans exist for co-located agencies/building occupants (federal, state); where their plans are absent in instructions, this plan will be in effect. -
Emergency Preparedness for COVID-19: Experience from One District General Hospital in Wuhan
4 Editorial Page 1 of 4 Emergency preparedness for COVID-19: experience from one district general hospital in Wuhan Yuetian Yu1#, Chunhui Xu2#, Cheng Zhu3, Qingyun Li4, Erzhen Chen3 1Department of Critical Care Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 2Clinical Laboratory Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; 3Department of Emergency Medicine, 4Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China #These authors contributed equally to this work. Correspondence to: Erzhen Chen. Department of Emergency Medicine, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China. Email: [email protected]. Received: 28 June 2020; Accepted: 04 September 2020; Published: 30 October 2020. doi: 10.21037/jeccm-20-97 View this article at: http://dx.doi.org/10.21037/jeccm-20-97 As a newly infectious disease, COVID-19 was first reported admitted on January 27th. The number of patients admitted at the end of December 2019 and now has become a global had reached 600 in the next three days and 15% of them pandemic (1). By August 20th, a total of 22,213,869 cases were critically ill who need organ support, especially the were confirmed in over 200 countries, including 781,677 respiratory support. However, insufficient oxygen supply death cases (2), which resulted in a challenge of medical and lack of ventilators brought great obstacles for the care system. During the first 2 months of 2020, the same rescue of these patients. -
Early History of Infectious Disease
© Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time. -
Eye Disease 1 Eye Disease
Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo -
Osteoporosis in Premenopausal Women: a Clinical Narrative Review by the ECTS and the IOF
This is a repository copy of Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/162028/ Version: Accepted Version Article: Pepe, J., Body, J.-J., Hadji, P. et al. (8 more authors) (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. The Journal of Clinical Endocrinology & Metabolism. ISSN 0021-972X https://doi.org/10.1210/clinem/dgaa306 This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Clinical Endocrinology and Metabolism following peer review. The version of record Jessica Pepe, Jean-Jacques Body, Peyman Hadji, Eugene McCloskey, Christian Meier, Barbara Obermayer-Pietsch, Andrea Palermo, Elena Tsourdi, M Carola Zillikens, Bente Langdahl, Serge Ferrari, Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF, The Journal of Clinical Endocrinology & Metabolism, dgaa306 is available online at: https://doi.org/10.1210/clinem/dgaa306 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. -
Syphilis and Theories of Contagion Curtis V
Syphilis and Theories of Contagion Curtis V. Smith, Doctoral Candidate Professor of Biological Sciences Kansas City Kansas Community College Abstract Syphilis provides a useful lens for peering into the history of early modern European medicine. Scholarly arguments about how diseases were transmitted long preceded certain scientific information about the etiology or cause of disease in the late 19th century. Compared to the acute and widely infectious nature of bubonic plague, which ravaged Europe in the mid-15th century, syphilis was characterized by the prolonged chronic suffering of many beginning in the early 16th century. This study reveals the historical anachronisms and the discontinuity of medical science focusing primarily on the role of Girolamo Fracastoro (1478-1553) and others who influenced contagion theory. Examination of contagion theory sheds light on perceptions about disease transmission and provides useful distinctions about descriptive symptoms and pathology. I. Introduction Treponema pallidum is a long and tightly coiled bacteria discovered to be the cause of syphilis by Schaudinn and Hoffman on March 3, 1905. The theory of contagion, or how the disease was transmitted, was vigorously debated in Europe as early as the sixteenth century. Scholarly arguments about how diseases were transmitted long preceded scientific information about the etiology or cause of disease. The intense debate about syphilis was the result of a fearsome epidemic in Europe that raged from 1495-1540. Compared to the Black Death, which had a short and sudden acute impact on large numbers of people one hundred and fifty years earlier, syphilis was characterized by the prolonged chronic suffering of many. -
Pathology and Epidemics
Chapter 8 Pathology and Epidemics As physicians, the Russell brothers were frequently exposed to epidemic dis- eases.1 Fevers, of great interest to eighteenth-century physicians, were thought to be diseases rather than symptoms of diseases. “The common epidemic diseases at Aleppo are Continual, Intermittent, Remittent fevers, Malignant Remittents,2 and regular and anomalous Erratic fevers to which children are liable,3 Diarrhoea, Dysentery, Pleurisy, Peripneumony,4 Quinsy,5 Rheumatism6 and Ophthalmia,7 common in Aleppo, which all return as regularly as the seasons”,8 as well as the plague – and smallpox that was “sometimes very fatal”.9 Other endemic diseases,10 many that targeted children, included measles, Chincough,11 Putrid Fevers, Petechial,12 and Scarlet Fevers. It is not surprising that the Russells focused on the prognosis, signs, symptoms and treatment of various diseases, including Cutaneous leishmaniasis, smallpox and the plague. 1 Hawgood, “Alexander Russell”, pp. 1–6; Starkey, “Contagion followed”; Aleppo Observed, pp. 164–178. 2 Aleppo2 ii: 300. i.e. typhoid. 3 SP 110/74. In a letter to a patient in Cyprus, Patrick recommended cold baths be taken in the cool of the morning, 11 October 1760. Laidlaw, British in the Levant, p. 145. 4 Respiratory diseases and pneumonia. 5 Peritonsillar abscess. 6 Alexander’s work is cited by Henry William Fuller, On rheumatism, rheumatic gout, and sciatica (London: J. Churchill, 1860), p. 419. 7 Aleppo2 ii: 299, 322. On ophthalmia, see Aleppo2 ii: 299–300. 8 Boott, John Armstrong, vol. 1, p. 114. 9 Volney, Voyage en Syrie, vol. 1, p. 362. 10 Davis, Aleppo, p. -
In the Prevention of Occupational Diseases 94 7.1 Introduction
Report on the current situation in relation to occupational diseases' systems in EU Member States and EFTA/EEA countries, in particular relative to Commission Recommendation 2003/670/EC concerning the European Schedule of Occupational Diseases and gathering of data on relevant related aspects ‘Report on the current situation in relation to occupational diseases’ systems in EU Member States and EFTA/EEA countries, in particular relative to Commission Recommendation 2003/670/EC concerning the European Schedule of Occupational Diseases and gathering of data on relevant related aspects’ Table of Contents 1 Introduction 4 1.1 Foreword .................................................................................................... 4 1.2 The burden of occupational diseases ......................................................... 4 1.3 Recommendation 2003/670/EC .................................................................. 6 1.4 The EU context .......................................................................................... 9 1.5 Information notices on occupational diseases, a guide to diagnosis .................................................................................................. 11 1.6 Objectives of the project ........................................................................... 11 1.7 Methodology and sources ........................................................................ 12 1.8 Structure of the report .............................................................................. 15 2 Developments -
Level I Syllabus
LEVEL I SYLLABUS 1 ACDT Course Learning Objectives Upon Completion, Those Enrolled Will Be MODULE Prepared To... The Language of Dermatology 1. Define and spell the following cutaneous lesions/descriptors: a. Macule b. Patch c. Papule d. Nodule e. Cyst f. Plaque g. Wheal h. Vesicle i. Bulla j. Pustule k. Erosion l. Ulcer m. Atrophy n. Scaling o. Crusting p. Excoriations q. Fissures r. Lichenification s. Erythematous t. Violaceous u. Purpuric v. Hypo/Hyperpigmented w. Linear x. Annular y. Nummular/Discoid z. Blaschkoid aa. Morbilliform bb. Polycyclic cc. Arcuate dd. Reticular Collecting & Documenting Patient History Part I 1. Describe the importance of documentation and chart review, while properly collecting dermatologyspecific medical history components, including: a. Chief Complaint b. Past Medical History c. Family History d. Medications e. Allergies Collecting & Documenting Patient History Part II 1. Demonstrate the proper collection of dermatologyspecific medical history and explain the significance of the following: a. Social History b. Review of Systems c. History of Present Illness Anatomy 1. Spell and document the following directional indicators while applying them to the appropriate anatomical landmarks: a. Proximal/Distal b. Superior/Mid/Inferior c. Anterior/Posterior d. Medial/Lateral e. Dorsal/Ventral 2. Spell and identify specific anatomical locations involving the: a. Scalp b. Forehead c. Ears d. Eyes e. Nose f. Cheeks g. Lips h. Chin i. Neck j. Back k. Upper extremity l. Hands m. Nails n. Chest o. Abdomen p. Buttocks q. Hips r. Lower extremity s. Feet Skin Structure and Function 1. Identify and spell the three primary layers of skin: a. -
European Conference on Rare Diseases
EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia -
Heberden Society
Ann Rheum Dis: first published as 10.1136/ard.25.1.86-b on 1 January 1966. Downloaded from Ann. rheum. Dis. (1966), 25, 86 HEBERDEN SOCIETY OFFICERS, 1966 Junior Hon. Secretary: Dr. J. A. Cosh President: Dr. Oswald Savage Hon. Librarian: Dr. W. S. C. Copeman President-Elect: Dr. J. J. R. Duthie PROGRAMME OF MEETINGS, 1966 March 25: Clinical Meeting, Rheumatism Research Hon. Treasurer: Wing, Birmingham. May 20: Meeting at Harrogate. Dr. F. Dudley Hart October 7: Heberden Round conducted by Dr. R. M. Mason at the London Hospital. Senior Hon. Secretary: November 18: Heberden Oration by Prof. E. G. L. Dr. C. F. Hawkins, Bywaters and Annual General Meeting at the Wellcome Rheumatism Research Wing, Foundation, London. Annual Dinner at the Royal Queen Elizabeth Hospital, Birmingham, 15 College of Physicians, Regents Park, London. by copyright. DR. HUGH CLEGG Dr. Hugh Clegg retired from the Editorship of the in 1945, soon after the war. He has always exerted an British Medical Journal at the beginning of this year and active influence and rheumatology in Great Britain owes so also from the Editorial Board of the Annals. It was him much. due to his foresight and help that our Journal was The Editor and members of the Editorial Committee adopted by the British Medical Association as one of and Board will miss his wise guidance, but wish him well their quarterly specialist journals which he inaugurated in his retirement. http://ard.bmj.com/ LIGUE INTERNATIONALE CONTRE LE RHUMATISME XI International Congress of Rheumatology, Argentina, 1965 on September 28, 2021 by guest. -
Neurodegeneration in Accelerated Aging
DOCTOR OF MEDICAL SCIENCE DANISH MEDICAL JOURNAL Neurodegeneration in Accelerated Aging Morten Scheibye-Knudsen This review has been accepted as a thesis together with 7 previously published pa- pers by the University of Copenhagen, October 16, 2014 and defended on January 14, 2016 Official opponents: Alexander Bürkle, University of Konstanz Lars Eide, University of Oslo Correspondence: Center for Healthy Aging, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen E-mail: [email protected] Dan Med J 2016;63(11):B5308 INTRODUCTION The global elderly population has been progressively increasing throughout the 20th century and this growth is projected to per- sist into the late 21st century resulting in 20% of the total world population being aged 65 or more by the year 2100 (Figure 1). 80% of the total cost of health care is accrued after 40 years of Figure 2. The phenotype of human aging. age where chronic diseases become prevalent [1, 2]. With an ex- that appear to regulate the aging process [4,5]. These include the ponential increase in health care costs, it follows that the chronic insulin and IGF-1 signaling cascades [4], protein synthesis and diseases that accumulate in an aging population poses a serious quality control [6], regulation of cell proliferation through factors socioeconomic problem. Finding treatments to age related dis- such as mTOR [7], stem cell maintenance 8 as well as mitochon- eases, therefore becomes increasingly more pertinent as the pop- drial preservation [9]. Most of these pathways are conserved ulation ages. Even more so since there appears to be a continu- through evolution and appear to regulate aging in many lower or- ous increase in the prevalence of chronic diseases in the aging ganisms.